Status:
WITHDRAWN
Hyperbaric Oxygen for Carbon Monoxide Induced Chronic Encephalopathy
Lead Sponsor:
University of Nebraska
Conditions:
Carbon Monoxide Poisoning
Chronic Encephalopathy
Eligibility:
All Genders
10-90 years
Phase:
NA
Brief Summary
In some patients, a few days or weeks after recovery from carbon monoxide poisoning, new symptoms develop. These can affect mood, ability to think or remember clearly, and movements. Some people devel...
Detailed Description
Carbon monoxide (CO) poisoning is a leading cause of unintentional poisoning deaths in the United States. After a period of apparent recovery, survivors of acute CO-poisoning can develop a potentially...
Eligibility Criteria
Inclusion
- CO induced neurological or cognitive sequelae assessed as at least mild (e.g. UPDRS part 3 (motor)\>15).
- chronicity- signs or symptoms present for greater than one year after exposure.
Exclusion
- age \>90 or less than 10 years
- other morbidities which may contribute to chronic neurocognitive deficits (such as traumatic brain injury, poisoning by other toxins, other neurodegenerative diseases)
- pregnancy (if a subject becomes pregnant she will be removed from the study)
- routine contraindications to hyperbaric oxygen
Key Trial Info
Start Date :
June 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 6 2023
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04118491
Start Date
June 6 2023
End Date
June 6 2023
Last Update
September 3 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.